ASHPOfficial

Five recipients of the 2025 ASHP Foundation Literature Awards discuss their projects and approaches to pharmacy research.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses how an interdisciplinary clinical decision support (CDS) team utilizes user feedback through an integrated home-grown system. We'll focus on the team’s journey through responding to feedback, tracking enhancements generated by the feedback, and improvements to the process.  Listeners will learn how user-generated feedback on electronic health record alerts can be efficiently triaged and managed by an interdisciplinary CDS team, with a focus on therjourney from first using the feedback to the current state of the process.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Anastasiya Shor, director of the drug information center and assistant professor at Touro College of Pharmacy. She shares what inspired her to pursue a career in pharmacy and offers insight into the vital role pharmacists play in supporting patients. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.

Pharmacists can play an important role in understanding the ongoing risks and burden of disease with COVID-19, identifying high-risk individuals including hospitalized patients who would benefit from treatment, evaluating recent clinical evidence supporting the use of antiviral therapies, and ensuring access to these therapies. This activity will discuss the most recent clinical evidence surrounding antivirals for COVID-19 and their role in improving patient outcomes.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is a brief review of emerging literature focusing on the potential use of GLP-1 receptor agonists in the treatment of mental health and substance use disorders. The episode explores how GLP-1 receptor agonists work to alter neurotransmitter systems and impact inflammation in the brain. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode explores the unique perspectives of pharmacy technician educators and their role in shaping the next generation of technicians. Listeners will gain insights into effective teaching strategies, current challenges in technician education, and innovative approaches to competency development. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Ben Anderson and Dr. Mike Ganio discuss the AJHP ASHP Report "Proceedings of the ASHP Autoverification Work Group: Findings and Guidance” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode will review the management of diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS) and euglycemic diabetic ketoacidosis (eDKA). Listeners will review the most current DKA/HHS guidelines and will be able to effective identify patients receiving insulin and fluid therapy that require changes in treatment to improve safety and disease resolution. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores how the federal government is attempting to lower prescription drug prices by examining the newest most-favored nation-focused drug pricing models, including TrumpRx and the GLOBE and GUARD mandatory models. We discuss how each model is structured and its potential impacts on patients, the healthcare system, and the pharmacy workforce.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Megan Musselman sits down with the Section of Clinical Specialists and Scientists Distinguished Service Awardee Martha Roberts to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.